Senti Biosciences
Christina Chung began their work experience as a Research Associate at DC3 Therapeutics in February 2021 and remained in that role until July 2022. Christina then joined Senti Biosciences in July 2022 as a Research Associate.
Christina Chung attended San Francisco State University from 2013 to 2020. However, no specific degree or field of study information was provided for this period.
Senti Biosciences
1 followers
Senti Biosciences is a developer of a programmable biology platform for cancer therapies.